The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

Item
http://www.wikidata.org/entity/Q33977116
Assessment of clinical and radiological response to sorafenib in hepatocellular carcinoma patientsHydrogen sulfide acts as a double-edged sword in human hepatocellular carcinoma cells through EGFR/ERK/MMP-2 and PTEN/AKT signaling pathwaysPiperlongumine selectively kills hepatocellular carcinoma cells and preferentially inhibits their invasion via ROS-ER-MAPKs-CHOP.Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma.Tat-Interacting Protein 30 (TIP30) Expression Serves as a New Biomarker for Tumor Prognosis: A Systematic Review and Meta-Analysis.Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinomaMutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL.Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden.Infiltrating immune cells and gene mutations in pancreatic ductal adenocarcinoma.Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with different phases of osteosarcoma.
P2860

The combination of HTATIP2 expression and microvessel density predicts converse survival of hepatocellular carcinoma with or without sorafenib

Item
http://www.wikidata.org/entity/Q33977116
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
The combination of HTATIP2 exp ...... noma with or without sorafenib
@ast
The combination of HTATIP2 exp ...... noma with or without sorafenib
@en
type
label
The combination of HTATIP2 exp ...... noma with or without sorafenib
@ast
The combination of HTATIP2 exp ...... noma with or without sorafenib
@en
prefLabel
The combination of HTATIP2 exp ...... noma with or without sorafenib
@ast
The combination of HTATIP2 exp ...... noma with or without sorafenib
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932
P356
P1433
P1476
The combination of HTATIP2 exp ...... noma with or without sorafenib
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P932